Glucotrack, Inc.
GCTK- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001506983
No open-market purchases or sales by Glucotrack, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Glucotrack, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 3 | 7 | +4 |
| Shares | 29.9K | 55.1K | +25.1K (+83.9%) |
| Value | $60.2K | $132.7K | +$72.5K (+120.5%) |
New holders (4)
Institutions that held Glucotrack, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 27,161 | $65.5K | 0.00% |
| Morgan Stanley | 500 | $1.21K | 0.00% |
| Tower Research Capital LLC (TRC) | 432 | $1.04K | 0.00% |
| Bank of America Corp | 31 | $75 | 0.00% |
Sold out (0)
Institutions that held Glucotrack, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
None.